1. PD-002A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis. (20th June 2018) Authors: Chajon, E; Pracht, M; De Baere, T; Nguyen, F; Bronowicki, J; Vendrely, V; Baumann, A; Croisé-Laurent, V; Rio, E; Rolland, Y; Le Sourd, S; Gustin, P; Perret, C; Mornex, F; Peiffert, D; Merle, P; Deutsch, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-002A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis. (20th June 2018) Authors: Chajon, E; Pracht, M; De Baere, T; Nguyen, F; Bronowicki, J; Vendrely, V; Baumann, A; Croisé-Laurent, V; Rio, E; Rolland, Y; Le Sourd, S; Gustin, P; Perret, C; Mornex, F; Peiffert, D; Merle, P; Deutsch, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SO-006Hafnium oxide nanoparticles activated by SBRT: a new interventional radiation therapy approach for the treatment of unresectable liver cancers. (2nd July 2019) Authors: Baere, T De; Pracht, M; Rolland, Y; Nguyen, F; Bronowicki, J; Vendrely, V; Cunha, A Sa; Baumann, A; Croisé-Laurent, V; Rio, E; Sourd, S Le; Gustin, P; Perret, C; Peiffert, D; Deutsch, E; Chajon, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗